vs

Side-by-side financial comparison of EXPONENT INC (EXPO) and P10, Inc. (PX). Click either name above to swap in a different company.

EXPONENT INC is the larger business by last-quarter revenue ($166.3M vs $81.0M, roughly 2.1× P10, Inc.). EXPONENT INC runs the higher net margin — 17.8% vs 11.7%, a 6.1% gap on every dollar of revenue. On growth, EXPONENT INC posted the faster year-over-year revenue change (14.3% vs -4.7%). Over the past eight quarters, P10, Inc.'s revenue compounded faster (10.7% CAGR vs 8.8%).

Exponent, Inc. is an American engineering and scientific consulting firm. Exponent has a team of scientists, physicians, engineers, and business consultants which performs research and analysis in more than 90 technical disciplines. The company operates 20 offices in the United States and five offices overseas.

P10, Inc. is a global alternative investment management firm that offers a diversified portfolio of investment solutions spanning private equity, private credit, real assets and venture capital. It primarily caters to institutional clients including pension funds, endowments, foundations, and high-net-worth individuals across North America, Europe, and Asia Pacific.

EXPO vs PX — Head-to-Head

Bigger by revenue
EXPO
EXPO
2.1× larger
EXPO
$166.3M
$81.0M
PX
Growing faster (revenue YoY)
EXPO
EXPO
+19.0% gap
EXPO
14.3%
-4.7%
PX
Higher net margin
EXPO
EXPO
6.1% more per $
EXPO
17.8%
11.7%
PX
Faster 2-yr revenue CAGR
PX
PX
Annualised
PX
10.7%
8.8%
EXPO

Income Statement — Q1 FY2027 vs Q4 FY2025

Metric
EXPO
EXPO
PX
PX
Revenue
$166.3M
$81.0M
Net Profit
$29.6M
$9.5M
Gross Margin
Operating Margin
24.9%
31.9%
Net Margin
17.8%
11.7%
Revenue YoY
14.3%
-4.7%
Net Profit YoY
11.0%
79.0%
EPS (diluted)
$0.59
$0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EXPO
EXPO
PX
PX
Q1 26
$166.3M
Q4 25
$147.1M
$81.0M
Q3 25
$142.0M
$75.9M
Q2 25
$145.5M
$72.7M
Q1 25
$136.8M
$67.7M
Q4 24
$85.0M
Q3 24
$136.3M
$74.2M
Q2 24
$140.5M
$71.1M
Net Profit
EXPO
EXPO
PX
PX
Q1 26
$29.6M
Q4 25
$28.0M
$9.5M
Q3 25
$26.6M
$2.1M
Q2 25
$26.6M
$3.4M
Q1 25
$23.6M
$4.5M
Q4 24
$5.3M
Q3 24
$26.0M
$1.4M
Q2 24
$29.2M
$7.0M
Operating Margin
EXPO
EXPO
PX
PX
Q1 26
24.9%
Q4 25
19.7%
31.9%
Q3 25
12.1%
14.1%
Q2 25
30.5%
24.4%
Q1 25
19.9%
16.6%
Q4 24
26.9%
Q3 24
19.0%
11.9%
Q2 24
25.4%
23.7%
Net Margin
EXPO
EXPO
PX
PX
Q1 26
17.8%
Q4 25
19.1%
11.7%
Q3 25
18.7%
2.8%
Q2 25
18.3%
4.7%
Q1 25
17.2%
6.7%
Q4 24
6.2%
Q3 24
19.1%
1.9%
Q2 24
20.8%
9.8%
EPS (diluted)
EXPO
EXPO
PX
PX
Q1 26
$0.59
Q4 25
$0.55
$0.08
Q3 25
$0.52
$0.02
Q2 25
$0.52
$0.03
Q1 25
$0.45
$0.04
Q4 24
$0.05
Q3 24
$0.50
$0.01
Q2 24
$0.57
$0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EXPO
EXPO
PX
PX
Cash + ST InvestmentsLiquidity on hand
$118.6M
$28.2M
Total DebtLower is stronger
$373.2M
Stockholders' EquityBook value
$338.3M
$403.5M
Total Assets
$687.4M
$928.3M
Debt / EquityLower = less leverage
0.93×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EXPO
EXPO
PX
PX
Q1 26
$118.6M
Q4 25
$207.4M
$28.2M
Q3 25
$231.8M
$40.0M
Q2 25
$245.1M
$33.4M
Q1 25
$258.9M
$74.4M
Q4 24
$67.5M
Q3 24
$219.7M
$61.5M
Q2 24
$203.3M
$31.2M
Total Debt
EXPO
EXPO
PX
PX
Q1 26
Q4 25
$373.2M
Q3 25
$393.4M
Q2 25
$373.0M
Q1 25
$357.2M
Q4 24
$319.8M
Q3 24
$319.4M
Q2 24
$300.6M
Stockholders' Equity
EXPO
EXPO
PX
PX
Q1 26
$338.3M
Q4 25
$402.9M
$403.5M
Q3 25
$427.8M
$396.8M
Q2 25
$441.4M
$388.9M
Q1 25
$421.1M
$374.3M
Q4 24
$386.9M
Q3 24
$410.3M
$394.1M
Q2 24
$393.2M
$396.9M
Total Assets
EXPO
EXPO
PX
PX
Q1 26
$687.4M
Q4 25
$761.4M
$928.3M
Q3 25
$759.4M
$936.0M
Q2 25
$763.2M
$932.2M
Q1 25
$777.3M
$877.4M
Q4 24
$869.3M
Q3 24
$744.1M
$857.0M
Q2 24
$709.2M
$823.2M
Debt / Equity
EXPO
EXPO
PX
PX
Q1 26
Q4 25
0.93×
Q3 25
0.99×
Q2 25
0.96×
Q1 25
0.95×
Q4 24
0.83×
Q3 24
0.81×
Q2 24
0.76×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EXPO
EXPO
PX
PX
Operating Cash FlowLast quarter
$23.0M
Free Cash FlowOCF − Capex
$18.1M
FCF MarginFCF / Revenue
22.3%
Capex IntensityCapex / Revenue
6.0%
Cash ConversionOCF / Net Profit
2.43×
TTM Free Cash FlowTrailing 4 quarters
$14.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EXPO
EXPO
PX
PX
Q1 26
Q4 25
$32.7M
$23.0M
Q3 25
$36.2M
$-8.6M
Q2 25
$7.3M
$13.4M
Q1 25
$56.1M
$-4.7M
Q4 24
$101.0M
Q3 24
$29.7M
$27.5M
Q2 24
$48.3M
$34.8M
Free Cash Flow
EXPO
EXPO
PX
PX
Q1 26
Q4 25
$30.0M
$18.1M
Q3 25
$33.9M
$-9.5M
Q2 25
$5.5M
$11.6M
Q1 25
$53.5M
$-6.0M
Q4 24
$96.6M
Q3 24
$28.0M
$25.2M
Q2 24
$47.2M
$33.9M
FCF Margin
EXPO
EXPO
PX
PX
Q1 26
Q4 25
20.4%
22.3%
Q3 25
23.9%
-12.6%
Q2 25
3.8%
15.9%
Q1 25
39.1%
-8.9%
Q4 24
113.6%
Q3 24
20.5%
34.0%
Q2 24
33.6%
47.7%
Capex Intensity
EXPO
EXPO
PX
PX
Q1 26
Q4 25
1.8%
6.0%
Q3 25
1.6%
1.2%
Q2 25
1.2%
2.5%
Q1 25
1.9%
1.9%
Q4 24
5.2%
Q3 24
1.3%
3.0%
Q2 24
0.8%
1.3%
Cash Conversion
EXPO
EXPO
PX
PX
Q1 26
Q4 25
1.16×
2.43×
Q3 25
1.36×
-4.01×
Q2 25
0.27×
3.96×
Q1 25
2.38×
-1.05×
Q4 24
19.12×
Q3 24
1.14×
19.54×
Q2 24
1.65×
4.98×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EXPO
EXPO

Revenues before reimbursements$151.8M91%
Reimbursements$14.5M9%

PX
PX

Management Fees$78.1M96%
Advisory Fees$1.8M2%

Related Comparisons